HCL
Showing 1 - 25 of 3,429
Advanced Solid Tumor Trial (ZG0895 Hydrochloride for Injection)
Not yet recruiting
- Advanced Solid Tumor
- ZG0895 Hydrochloride for Injection
- (no location specified)
May 25, 2023
Rhinitis Allergic Trial (Fexofenadine HCL and pseudoephedrine HCL)
Not yet recruiting
- Rhinitis Allergic
- Fexofenadine HCL and pseudoephedrine HCL
- (no location specified)
Jan 31, 2023
Healthy Subject Trial in Seoul (Neomazine Tab. 100mg, Myungin Chlorpromazine HCl Tab. 100mg)
Completed
- Healthy Subject
- Neomazine Tab. 100mg
- Myungin Chlorpromazine HCl Tab. 100mg
-
Seoul, Korea, Republic ofWhan In Pharm.
Nov 23, 2023
Healthy Trial in Cairo (Gleptomet 50/1000(Metformin HCl & Sitagliptin), Janumet 50/1000(Metformin HCl & Sitagliptin))
Completed
- Healthy
- Gleptomet 50/1000(Metformin HCl & Sitagliptin)
- Janumet 50/1000(Metformin HCl & Sitagliptin)
-
Cairo, EgyptGenuine Research Center GRC
Mar 22, 2023
Wilson's Disease Trial in London (900mg TETA 4HCl Once Daily Formulation, 900mg TETA 4HCl Cuprior®)
Not yet recruiting
- Wilson's Disease
- 900mg TETA 4HCl Once Daily Formulation
- 900mg TETA 4HCl Cuprior®
-
London, United KingdomRichmond Pharmacology Ltd
Nov 7, 2023
Allergy Trial (cetirizine HCl Gummy, Zyrtec tablet 10mg)
Not yet recruiting
- Allergy
- cetirizine HCl Gummy
- Zyrtec tablet 10mg
- (no location specified)
May 18, 2022
Shoulder Pain Trial in Dallas (Single-injection bupivacaine HCl plus liposomal bupivacaine, Single-injection bupivacaine HCl
Enrolling by invitation
- Shoulder Pain
- Single-injection bupivacaine HCl plus liposomal bupivacaine
- Single-injection bupivacaine HCl plus a subsequent bupivacaine CISB
-
Dallas, TexasUT Southwestern Medical Center
Jul 1, 2022
Healthy Trial in Adelaide (TR-01-XRR (1), TR-01-XRR (2), TR-01-XRR (3))
Not yet recruiting
- Healthy
- TR-01-XRR (1)
- +6 more
-
Adelaide, South Australia, AustraliaCMAX Clinical Research
Feb 3, 2023
Inflammation: 9- and 12-Month Follow-Up Post Non-Surgical
Completed
- SRP
- +2 more
- Measurement of Biomarkers
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 21, 2022
Shoulder Pain Trial in New York (Liposomal Bupivacaine, 0.5% Bupivacaine HCL)
Completed
- Shoulder Pain
- Liposomal Bupivacaine
- 0.5% Bupivacaine HCL
-
New York, New YorkNYU Langone Health
Jan 3, 2022
Genetic Risk for Alzheimer's Disease Trial in Cleveland (donepezil HCL, Placebo)
Active, not recruiting
- Genetic Risk for Alzheimer's Disease
- donepezil HCL
- Placebo
-
Cleveland, OhioCleveland Clinic Center for Brain Health
May 16, 2022
Hypertension, Heart Failure Trial in San Antonio (Prazosin HCl 2mg, Prazosin HCl 1 mg, Prazosin HCl 5 mg)
Completed
- Hypertension
- Heart Failure
- Prazosin HCl 2mg
- +2 more
-
San Antonio, TexasClinical Trials of Texas, LLC
Jul 6, 2022
Hematological Malignancy, Leukemia, Multiple Myeloma Trial in Milwaukee (Evomela, Fludarabine, Total Body Irradiation)
Recruiting
- Hematological Malignancy
- Multiple Myeloma
- Evomela
- +2 more
-
Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
Oct 4, 2022
Post Operative Pain Trial in Karachi (Bupivacaine Hcl 0.25% Inj, Bupivacaine Hcl 0.25% Inj plus Dexmedetomidine 1micro/kg)
Completed
- Post Operative Pain
- Bupivacaine Hcl 0.25% Inj
- Bupivacaine Hcl 0.25% Inj plus Dexmedetomidine 1micro/kg
-
Karachi, Sindh, PakistanSindh Institute of Urology and Transplantation. Department of An
Jun 25, 2023
Four Second Line Pharmacological Strategies in Type 2 Diabetes
Active, not recruiting
- Cardiovascular Events
- +2 more
- SGLT2 inhibitor
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Feb 17, 2022
Leptomeningeal Tumor, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain Trial in United States
Recruiting
- Leptomeningeal Neoplasm
- +6 more
- Sapanisertib
- Telaglenastat Hydrochloride
-
Duarte, California
- +6 more
Dec 29, 2022
Erythematotelangiectatic Rosacea Trial in Charlotte, Houston (The Vbeam® Prima System, Oxymetazoline HCL 1% Cream)
Completed
- Erythematotelangiectatic Rosacea
- The Vbeam® Prima System
- Oxymetazoline HCL 1% Cream
-
Charlotte, North Carolina
- +1 more
Mar 18, 2022
Type1 Diabetes Trial in United States (HCL, verapamil 120mg tablet, non-HCL)
Completed
- Type1 Diabetes
- HCL
- +3 more
-
Palo Alto, California
- +5 more
Oct 31, 2022
Postoperative Pain, Cesarean Section Trial in Charlotte (Liposomal bupivacaine, Bupivacaine HCl)
Suspended
- Postoperative Pain
- Cesarean Section
- Liposomal bupivacaine
- Bupivacaine HCl
-
Charlotte, North CarolinaAtrium Health
Jan 27, 2023
Stimulant Use, Relapse, Cognitive Function Trial in Los Angeles (Contrave 8Mg-90Mg Extended-Release Tablet, Bupropion)
Not yet recruiting
- Stimulant Use
- +3 more
- Contrave 8Mg-90Mg Extended-Release Tablet
- Bupropion
-
Los Angeles, CaliforniaUniversity of California Los Angeles
Aug 31, 2022
Schizophrenia Trial in Seoul (Lurasidone HCL 160 mg, Quetiapine XR 600 mg)
Active, not recruiting
- Schizophrenia
- Lurasidone HCL 160 mg
- Quetiapine XR 600 mg
-
Seoul, Seoul, Dongjak-gu, Korea, Republic ofBorame Medical Center
Jul 19, 2022
Exercise-induced Arterial Hypoxemia Trial in Bloomington (Nedocromil Sodium, Cetirizine HCl, Placebo)
Recruiting
- Exercise-induced Arterial Hypoxemia
- Nedocromil Sodium
- +2 more
-
Bloomington, Indiana1025 E Seventh St
Jan 18, 2022
Pain, Postoperative, Brachial Plexus Block Trial in Rochester (Bupivacaine HCl, Liposomal bupivacaine + Bupivacaine Hcl 0.5%
Recruiting
- Pain, Postoperative
- Brachial Plexus Block
- Bupivacaine HCl
- Liposomal bupivacaine + Bupivacaine Hcl 0.5% Inj
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 14, 2022
Fabry Disease Trial in Worldwide (migalastat HCl 150 mg)
Recruiting
- Fabry Disease
- migalastat HCl 150 mg
-
Atlanta, Georgia
- +8 more
Jan 11, 2023